CTK7A is a curcumin derivative with anticancer activity by inhibiting the HAT activity of p300 and reducing the autoacetylation of p300, thereby affecting its interaction with HIF-1alpha. The inhibition of CTK7A leads to decreased HIF-1alpha accumulation and activity, which can be used for cancer research[1].